1 Min Read
June 26 (Reuters) - Conatus Pharmaceuticals Inc:
* FDA grants conatus orphan drug designation for idn-7314 for the treatment of PSC Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.